Heart failure is the number one cause of hospitalization in the US. Unfortunately, heart failure cannot be cured, and patients often find themselves returning to the emergency room again and again. Currently, the only solution is invasive, which is a barrier for patients. Less than 1% of heart failure patients received this treatment. CardioStory believes that a non-invasive solution could help more patients. That's why CardioStory is developing a non-invasive filling pressure monitoring device to help reduce patients' re-hospitalization rate.
Participating in the MedTech Accelerator program helps us build connections with experts from different aspects of the healthcare ecosystem. It also helps us listen to more voices from the potential users of the device.
"The accelerator program has helped pave the way for our startup journey, from concept to commercialization. By partnering with experts from Mayo Clinic and ASU, CardioStory expects to bring more innovative technology to patients."